Sagimet Biosciences Inc.
Total Trades
14
Buys
4
Sells
9
Largest Trade
N/A
Insiders
7
Institutional Funds
68
Inst. Value
$1M+
Activist Filings
19
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Happel David | President & CEO | SELL | $50K–$100K | 12K | $5.36 | Feb 12, 2026 |
| Chauche Thierry | CFO | SELL | $1K–$15K | 1K | $5.36 | Feb 12, 2026 |
| Martins Eduardo Bruno | Chief Medical Offi… | SELL | $15K–$50K | 4K | $5.36 | Feb 12, 2026 |
| Rozek Elizabeth | Chief Legal & Admi… | SELL | $1K–$15K | 3K | $5.36 | Feb 12, 2026 |
| Kemble George | Executive Chairman | SELL | $100K–$500K | 38K | $7.69 | Nov 21, 2025 |
| Happel David | President & CEO | SELL | $500K+ | 65K | $9.13 | Jul 23, 2025 |
| Martins Eduardo Bruno | Chief Medical Offi… | SELL | $50K–$100K | 8K | $9.13 | Jul 23, 2025 |
| Rozek Elizabeth | General Counsel an… | SELL | $50K–$100K | 11K | $9.13 | Jul 23, 2025 |
| Happel David | President & CEO | BUY | $50K–$100K | 12K | $5.27 | Mar 28, 2024 |
| Happel David | President & CEO | BUY | $1K–$15K | 590 | $2.35 | Nov 21, 2023 |
| NEW ENTERPRISE ASSOCIATES 13 LP | 10% Owner | SELL | $1K–$15K | 662 | $16.00 | Jul 20, 2023 |
| NEW ENTERPRISE ASSOCIATES 13 LP | 10% Owner | BUY | $100K–$500K | 30K | $16.00 | Jul 20, 2023 |
| SEIDENBERG BETH C | Director | BUY | $500K+ | 47K | $16.00 | Jul 20, 2023 |
| SEIDENBERG BETH C | Director | GRANT | N/A | 39K | — | Jul 20, 2023 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 68 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Blue Owl Capital Holdings LP | 1.2M | $1M+ | SH |
| Blue Owl Capital Holdings LP | 1.2M | $1M+ | SH |
| Affinity Asset Advisors, LLC | 1.1M | $1M+ | SH |
| VANGUARD GROUP INC | 1.1M | $1M+ | SH |
| HHLR ADVISORS, LTD. | 725K | $1M+ | SH |
| Siren, L.L.C. | 725K | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 343K | $1M+ | SH |
| RAYMOND JAMES FINANCIAL INC | 284K | $1M+ | SH |
| Hudson Bay Capital Management LP | 250K | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 243K | $1M+ | SH |
| Pale Fire Capital SE | 222K | $1M+ | SH |
| Point72 Asset Management, L.P. | 176K | $1M+ | SH |
| UBS Group AG | 175K | $1M+ | SH |
| Verition Fund Management LLC | 155K | $500K+ | SH |
| FNY Investment Advisers, LLC | 143K | $500K+ | SH |
| MARSHALL WACE, LLP | 130K | $500K+ | SH |
| GOLDMAN SACHS GROUP INC | 126K | $500K+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 123K | $500K+ | SH |
| STATE STREET CORP | 117K | $500K+ | SH |
| RB Capital Management, LLC | 97K | $500K+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
KPCB Pandemic and Bio Defense Fund, LLC
SC 13G/A · Dec 18, 2025
0.0%
0 shares
SC 13G/A · Nov 14, 2025
4.8%
1.5M shares
Point72 Asset Management, L.P.
SC 13G/A · Aug 14, 2025
0.0%
0 shares
SC 13G · Aug 14, 2025
8.3%
2.6M shares
SC 13G/A · Jun 24, 2025
4.9%
1.5M shares
SC 13G · May 20, 2025
5.4%
1.7M shares
Point72 Asset Management, L.P.
SC 13G/A · May 15, 2025
5.7%
1.8M shares
New Enterprise Associates 13, L.P.
SC 13G/A · May 13, 2025
0.0%
0 shares
SC 13G/A · Feb 14, 2025
4.3%
1.3M shares
Point72 Asset Management, L.P.
SC 13G/A · Nov 15, 2024
8.0%
2.5M shares
SC 13G · Nov 14, 2024
5.5%
1.7M shares
Hillhouse Investment Management, Ltd.
SC 13G/A · Nov 14, 2024
2.4%
725K shares
SC 13G/A · Nov 14, 2024
5.0%
1.5M shares
SC 13G/A · Mar 11, 2024
2.4%
742K shares
(S) New Enterprise Associates 13, L.P.
SC 13G · Feb 14, 2024
6.6%
2.0M shares
Hillhouse Investment Management, Ltd.
SC 13G · Feb 14, 2024
6.8%
1.4M shares
SC 13G · Feb 14, 2024
6.8%
1.5M shares
KPCB Pandemic and Bio Defense Fund, LLC (“KPCB PBD”)
SC 13G · Feb 14, 2024
6.3%
1.9M shares
SC 13G · Sep 11, 2023
12.3%
2.6M shares